Presented ByDr Moritz Fürstenau, University of Cologne, Germany
TrialPhase 2, CLL2-BAAG ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:01
Presented ByDr Brad Rovin, Ohio State University, OH, USA
TrialPhase 2, NOBILITY ConferenceASN 2023
TypeNews article
28 November 2023 14:41
Presented ByProf. Barbara Eichhorst, University Hospital Cologne, Germany
TrialPhase 3, GAIA/CLL13 ConferenceEHA 2022
TypeNews article
1 July 2022 11:43
ExpertDr Jennifer Woyach, Ohio State University, OH, USA
TrialPhase 3, Alliance A041202 ConferenceASH 2021
3 February 2022 23:22
ExpertDr. Talha Munir, Leeds Teaching Hospitals NHS Trust, UK
TrialPhase 3, GLOW ConferenceASH 2021
3 February 2022 23:15
Presented ByDr. John Byrd, Ohio State University College of Medicine, USA
TrialPhase 3, ELEVATE-TN JournalPhysician's Weekly ConferenceASCO 2021
6 August 2021 11:20
Presented ByDr Jeff Sharman, US Oncology Network, USA
TrialPhase 3, ELEVATE-TN ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 13:50
Presented ByDr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands
TrialPhase 2, HOVON 139/GiVe ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 13:38
Presented ByProf. Arnon Kater, Amsterdam University Medical Centres, the Netherlands
TrialPhase 2, GLOW ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 13:33
Presented ByProf. Joan T. Merrill, Oklahoma Medical Research Foundation, USA
ConferenceACR 2020
TypePeer-reviewed article
18 January 2021 10:54
Presented ByDr Eugen Tausch, University of Ulm, Germany
TrialCLL14 ConferenceEHA 2019
TypePeer-reviewed article
9 August 2019 22:38
Presented ByProf. Wojciech Jurczak, Jagiellonian University, Poland
ConferenceEHA 2019
TypePeer-reviewed article
9 August 2019 17:13
Presented ByDr Kirsten Fischer, University of Cologne, Germany
TrialPhase 3, CLL14 ConferenceEHA 2019
TypePeer-reviewed article
9 June 2019 23:28